|
November 13, 2009
Upper Michigan Brain Tumor Center at Marquette General Hospital joins nationwide research project
The Upper Michigan Brain Tumor Center at Marquette General Hospital recently affiliated with Moffitt Cancer Center based in Tampa, Fla., to participate in a nationwide tumor research project.
The project, known as Total Cancer Care (TCC™), is a partnership of patients, doctors and researchers trying to advance cancer care through personalized medicine.
During the past three years, Moffitt has enrolled more than 43,000 cancer patients as part of the Total Cancer Care protocol. The molecular biologists identify biological markers unique to each tumor. From there, researchers analyze patients’ responses to specific treatments, which may lead to more individualized care aimed at providing rapid improvements with fewer side effects.
There are 17 Total Cancer Care sites in the United States. Total Cancer Care staff came to MGH in October to meet with the Upper Michigan Brain Tumor Center Team.
For more information, please call the Upper Michigan Brain Tumor Center at
(906) 225-4575.
Staff from Moffitt Cancer Center based in Tampa, Fla., visited Marquette General Hospital to discuss an affiliation agreement between the two organizations.
The Upper Michigan Brain Tumor Center at MGH has joined 16 other sites across the nation that will submit tissue samples for analysis in an effort to individualize treatments that will be more effective and have fewer side effects.
Medical Director of the Brain Tumor Center, Dr. Richard Rovin (top right) of Marquette General Neurosurgery, and lead MGH pathologist Dr. John Weiss (bottom right), review procedural questions with Audra McMillian (bottom left), BS, CCRA, certified clinical research associate for the Moffitt Cancer Center; and Rana Zaki (top left), MPH, clinical project manager for Moffitt Cancer Center.
|
